Replies to post #41253 on Amarin Corp Plc (AMRN)

[zumantu]

ggwpq,
yes I have been told that directly from a rep - there is excitement because generic L is creating the reason to switch patients and it dovetails with new detailing message of focusing on LDL-C

so good alignment of opportunity due to inferior generic L and new detailing message